Managing mixed dyslipidemia in special populations.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 2923824)

Published in Prev Cardiol on January 01, 2010

Authors

Michael Miller1

Author Affiliations

1: Department of Medicine, University of Maryland Hospital, Baltimore, MD, USA. mmiller@medicine.umaryland.edu

Associated clinical trials:

Niacin Plus Statin to Prevent Vascular Events | NCT00120289

A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome | NCT00658515

Articles cited by this

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA (2002) 25.68

Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA (2001) 17.91

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32

Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care (2001) 14.03

Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med (2009) 12.38

Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science (2003) 11.39

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care (2005) 7.05

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ (2005) 6.83

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet (2007) 6.82

Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care (2004) 6.68

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med (2007) 6.31

Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol (2008) 5.19

NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes (2003) 5.11

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16

Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med (2001) 4.15

Menopause and risk factors for coronary heart disease. N Engl J Med (1989) 3.84

Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation (2003) 3.33

Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Investigators. Arch Intern Med (2000) 3.25

Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation (2006) 3.00

Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol (2008) 2.75

Recent trends in waist circumference and waist-height ratio among US children and adolescents. Pediatrics (2006) 2.63

Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study. Arterioscler Thromb Vasc Biol (2004) 2.50

Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J (2006) 2.22

Racial disparities in coronary heart disease: a sociological view of the medical literature on physician bias. Ethn Dis (2004) 1.92

Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med (2004) 1.74

Comparative effects of three popular diets on lipids, endothelial function, and C-reactive protein during weight maintenance. J Am Diet Assoc (2009) 1.68

Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol (2006) 1.66

BMI does not accurately predict overweight in Asian Indians in northern India. Br J Nutr (2001) 1.66

Risk factors that attenuate the female coronary disease advantage. Arch Intern Med (1995) 1.59

Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol. Circulation (1992) 1.45

Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease. Am J Cardiol (2008) 1.35

Metabolic syndrome and echocardiographic left ventricular mass in blacks: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation (2005) 1.29

ABC of obesity. Risk factors for diabetes and coronary heart disease. BMJ (2006) 1.19

Introduction: Globalization and the non-communicable disease epidemic. Obesity (Silver Spring) (2006) 1.09

Perspectives on dyslipidemia and coronary heart disease in women. J Am Coll Cardiol (2005) 1.04

The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study. J Intern Med (2007) 0.96

Centralized obesity and cardiovascular disease risk in Mexican Americans. Am J Epidemiol (1987) 0.91

Management of dyslipidemia in women in the post-hormone therapy era. J Gen Intern Med (2005) 0.82

Cardiovascular disease preventive measures for the older patient: an epidemiologic perspective. Am J Geriatr Cardiol (2006) 0.82

Ethnic differences in low-density lipoprotein particle size in hypertensive adults. J Clin Lipidol (2007) 0.80

Guidelines for management of high-risk African Americans with multiple cardiovascular risk factors: recommendations of an expert consensus panel. Ethn Dis (2007) 0.78